Now I have a thorough understanding of the paper. Let me write the consolidated review.

## Summary
2-3 sentence summary of the paper's contribution.

## Strengths
- strength 1 with evidence
- strength 2 with evidence

## Weaknesses
### Fatal
### Major
### Minor
### Trivial

## Nice-to-Haves

## Removed Points

## Novel Insights

## Suggestions

## Score and Decision

Let me now write the full review.

---

**Critical reasoning on the construct validity issue:**

The harsh critic claims this is a fatal flaw. However, the paper is transparent that it tests property #2 (clocks distinguish AAC from HC), and the AACs are defined by explicit criteria (decreased life expectancy, chronic, systemic). The paper does not claim its AACs are *proven* to drive epigenetic aging acceleration — it defines them as "putative aging-accelerating conditions" (Section 5, line 162) and discusses the limitation that blood-based clocks may detect disease-specific signals (Section 5, lines 166-168). The benchmark's usefulness does not hinge on proving the AACs cause *epigenetic* aging; it tests whether clocks can distinguish healthy from diseased states with known life-shortening effects. The construct validity concern is real but not fatal — it's a major limitation the paper partially acknowledges.

**On the cumulative score:** The paper admits the score is designed for "simplicity and interpretability" and that "there could be a more optimal solution." This transparency counts in the paper's favor but the weakness stands — the ranking depends on an unvalidated metric.

**On sample sizes:** The paper claims thresholds were chosen "to attain sufficient statistical power" but provides no power analysis. This is a valid minor weakness.

Let me now write the review.## Summary

This paper proposes ComputAgeBench, the first systematic, large-scale benchmark for evaluating epigenetic aging clocks. The authors define explicit, evidence-based criteria for selecting aging-accelerating conditions (AACs), collect and harmonize 66 public blood DNA methylation datasets covering 19 such conditions, and evaluate 13 published clock models across four tasks (relative acceleration detection, absolute acceleration detection, prediction accuracy, and bias). The main result is that second-generation clocks (PhenoAge, GrimAge variants) outperform first-generation clocks, consistent with the field's expectations but now confirmed in a unified, reproducible framework.

---

## Strengths

- **First systematic benchmark with principled, reproducible selection criteria.** The paper defines explicit AAC criteria (decreased life expectancy, chronic, systemic; Sec 3.1) and dataset selection criteria (open access, BSB samples, age range 18–90, Illumina BeadChip, minimum sample sizes; Sec 3.2). This moves beyond the ad-hoc comparisons in prior work and provides a standardized methodology the field can build on.

- **Substantial data collection and harmonization effort.** 66 datasets from 50+ studies covering 9 disease classes and 19 conditions, all harmonized under uniform preprocessing (Sec 3.3). This is a valuable community resource that enables more principled comparisons than previous small-scale studies.

- **Four distinct evaluation tasks that disentangle different aspects of clock behavior.** The AA2 (relative acceleration), AA1 (absolute acceleration), prediction accuracy, and bias tasks address properties that are often conflated. In particular, the bias task (Sec 3.5) explicitly addresses covariate shift — a known but often ignored confound in clock evaluation.

- **Reproducible pipeline.** The paper commits to a Google Colab notebook and code repositories (Sec 7), and all datasets are from open-access GEO sources. This lowers the barrier for replication and extension.

---

## Weaknesses

### Fatal

None. The paper's core contribution — a standardized benchmarking framework with harmonized datasets — is achieved. The limitations discussed below are significant but do not invalidate the paper's central offering.

### Major

- **Construct validity of the AAC-as-proxy assumption is unverified.** The entire benchmark rests on the assumption that the 19 selected conditions induce *epigenetic aging acceleration* (i.e., DNA methylation changes overlapping with age-related methylation) rather than disease-specific methylation patterns. The paper provides no analysis to distinguish these possibilities. As the authors note (Sec 5, lines 166–168), the strong performance on immune system diseases (mostly HIV) "supports the notion that the blood-based clocks might be implicitly attuned to such conditions" — which is exactly the ambiguity the benchmark does not resolve. A clock that merely detects disease-specific methylation could score well while a true aging clock that is insensitive to such disease signals could score poorly, and the benchmark would interpret both outcomes incorrectly. The paper's three AAC criteria (decreased life expectancy, chronic, systemic) are reasonable starting points, but they do not guarantee that the conditions drive *epigenetic* aging as measured by DNA methylation clocks. This limitation is acknowledged in the Discussion but not addressed.

- **No positive or negative control experiments.** The benchmark's sensitivity (can it detect a known aging accelerator?) and specificity (does it avoid false positives for conditions not expected to affect blood DNAm aging?) are entirely unknown. Including controls such as obesity or smoking (known to accelerate epigenetic aging in blood) and an acute infection (not expected to leave a lasting blood DNAm signature) would validate that the benchmark's statistical tests are functioning as intended. Without these, failures on specific disease classes (e.g., cardiovascular and metabolic diseases, where "all clocks failed") cannot be cleanly interpreted — they could reflect genuine clock limitations, insufficient statistical power, or the possibility that these conditions do not produce blood-based epigenetic aging signals detectable by existing clocks.

### Minor

- **Cumulative benchmarking score (Eq. 2) is ad hoc and unvalidated.** The score combines AA2 count, AA1 count, and a bias penalty term chosen for "simplicity and interpretability" (Sec 3.6). No sensitivity analysis, comparison to alternative aggregation methods, or external validation supports the claim that this score yields robust rankings. The paper openly acknowledges this ("there could be a more optimal solution"), which is commendable, but as the main comparative result (Table 1) relies on this score, the rankings remain provisional. However, the paper presents raw task scores (Table 1, Fig 3E/F) alongside the cumulative score, so readers can draw their own conclusions.

- **Statistical power is not assessed.** The inclusion thresholds (min 5 AAC samples per dataset, 10 AAC samples overall) are stated as sufficient for power (Sec 3.2), but no post-hoc power analysis, effect sizes, or confidence intervals are reported. With small group sizes in some datasets, a two-sample Welch's test has low power to detect realistic acceleration effects (e.g., 2–5 years), especially after FDR correction. This makes it difficult to distinguish true clock failures from test insufficiencies. The paper's claim to have set thresholds "to attain sufficient statistical power" is not supported by any analysis.

- **One-sided tests without sensitivity analysis.** The paper uses one-sided tests in both AA2 and AA1 tasks (Sec 3.5), assuming AACs only accelerate (never decelerate) aging. While this is a defensible choice given the AAC definition, a two-sided analysis or at least a justification of why deceleration cannot occur for these conditions would strengthen the results.

- **Potential data leakage not formally checked.** The paper states that "no data in the benchmark was used to train any of the selected clocks" (Sec 3.4) but does not describe a verification procedure. Given that both the benchmark datasets (GEO) and clock training sets originate from overlapping public repositories, some same-source overlap is possible. While unlikely to change the rankings significantly, this should be documented.

### Trivial

- Property #1 (age in biologically meaningful units) is tested but is essentially a minimum sanity check — any clock whose output can be rescaled to years will pass. This is not a meaningful discriminator between clocks.
- The third AAC criterion ("must manifest itself systemically") is defined with examples (bone fracture excluded) but would benefit from a more formal operationalization.
- The paper focuses on properties 1 and 2, but the Introduction defines four properties; this framing could mislead readers expecting a more comprehensive benchmark.

---

## Nice-to-Haves

- **Overlap analysis of AAC-associated CpGs with aging-associated CpGs:** Testing whether the CpGs driving clock predictions on AAC datasets are enriched for known age-related CpGs (e.g., from EWAS Catalog) would directly address the construct validity concern.
- **Null model baselines:** Reporting performance of a constant model (e.g., predicting median age) and a random model would contextualize clock scores.
- **Per-dataset effect sizes and confidence intervals:** Rather than just significance counts, reporting effect sizes (e.g., mean Δ difference between AAC and HC per dataset) would help readers assess biological as well as statistical significance.
- **Variance of bias across datasets:** The bias metric averages across datasets; reporting the distribution of Med(Δ) per dataset would reveal whether low overall bias hides high variance.

---

## Removed Points

These points are flagged to be removed, treat them with caution:

- **Harsh critic's claim that the lack of kidney/liver datasets "systematically underrepresents certain organ systems in a way that biases clock rankings."** — The paper explicitly discloses this limitation, and the absence of datasets meeting all five criteria is a data reality, not a design bias. The critic provides no evidence that this omission biases rankings toward any particular clock type.

- **Harsh critic's claim that "the paper does not discuss whether this bias is dataset-specific or global, nor how it varies across conditions."** — The bias task is explicitly designed to measure *systematic* (global) covariate shift (Sec 3.5). The paper's approach of computing Med(Δ) across HC samples from the entire dataset panel is a deliberate methodological choice to measure global bias; discussing per-dataset variance would be a separate analysis, not a required component of this task.

- **Harsh critic's claim about data leakage being "not verified for all 66 datasets against all training sets, and no data leakage check is described."** — The paper states that data was checked (Sec 3.4). While no explicit step-by-step procedure is described, the reasoning is that clock coefficients are published and fixed, and the benchmark datasets are from GEO studies published after or independently from clock training. This is standard practice in the field; requiring a formal data leakage audit for every combination is disproportionate.

- **Strength Finder's claim that the paper "provides a reproducible, openly accessible pipeline" — retained but noted that the code repository link is a placeholder ("will become available after the double-blind review" in Sec 7).** The commitment is stated; the actual availability cannot be verified. The datasets themselves are from GEO and are verifiable.

---

## Novel Insights

The most interesting finding beyond the paper's own contributions is the asymmetry in clock performance across disease classes: second-generation clocks dominate on immune system diseases (largely HIV) but all clocks fail on cardiovascular and metabolic diseases. This pattern, which the paper reports but does not deeply investigate, may reveal a structural limitation of blood-based clocks — they are inherently attuned to immune-cell methylation signatures but insensitive to conditions primarily affecting other organ systems. This has implications for the field's goal of developing truly systemic aging biomarkers.

---

## Suggestions

1. **Address the construct validity concern directly** by analyzing whether the CpGs driving clock predictions on AAC datasets are enriched for known aging-associated CpGs (from existing EWAS). If the same CpGs drive predictions across diverse AACs and overlap with age CpGs, this would validate the proxy assumption.
2. **Add control experiments** using at least one established aging accelerator (e.g., obesity, smoking, or HIV-positive datasets already in the collection) and one condition not expected to affect blood DNAm aging.
3. **Report effect sizes** (mean Δ difference between AAC and HC per dataset) alongside the significance counts to distinguish statistical from biological significance.
4. **Include a sensitivity analysis** comparing one-sided vs. two-sided test results, or justify the one-sided choice more explicitly.
5. **Validate the cumulative score** through a simple sensitivity analysis — test whether rankings change under alternative weighting schemes or penalty formulations.

---

## Score and Decision

The paper makes a genuine contribution: it provides the first systematic, reproducible benchmark for epigenetic aging clocks, backed by a substantial data harmonization effort and a well-structured evaluation framework. The weaknesses are real — particularly the unverified construct validity of the AAC-as-proxy assumption and the ad hoc cumulative score — but the paper is transparent about its limitations, and the core resource (66 harmonized datasets + evaluation pipeline) will be useful to the community regardless. The benchmark does not resolve the fundamental challenge of validating latent biological age, but it provides a standardized platform for comparison that the field has been lacking.

**Originality:** Moderate-high. First systematic benchmark in this space.  
**Importance of research question:** High. Standardized clock validation is a pressing need.  
**Claims well-supported:** Moderately. Main claims are supported but the construct validity gap weakens interpretation.  
**Soundness of experiments:** Moderate. Methodology is generally sound but lacks controls and power analysis.  
**Clarity of writing:** Good. Well-structured and transparent about limitations.  
**Value to research community:** High. The harmonized datasets and reproducible pipeline are significant resources.

MY FINAL SCORE: <pineapple>6.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>